{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:42:04Z","timestamp":1780760524475,"version":"3.54.1"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n            <jats:title>Summary:<\/jats:title>\n            <jats:p>There remain significant gaps in the evidence-based care of patients undergoing gender-affirming mastectomy with regard to implications for breast cancer development and screening. The current clinical evidence does not demonstrate an increased risk of breast cancer secondary to testosterone therapy in transgender patients. Gender-affirmation mastectomy techniques vary significantly with regard to the amount of residual breast tissue left behind, which has unknown implications for the incidence of postoperative breast cancer and need for screening. Subcutaneous mastectomy should aim to remove all gross breast parenchyma, although this is limited in certain techniques. Tissue specimens should also be routinely sent for pathologic analysis. Several cases of incidental breast cancer after subcutaneous mastectomy have been described. There is little evidence on the need for or types of postoperative cancer screening. Chest awareness is an important concept for patients that have undergone subcutaneous mastectomies, as clinical examination remains the most common reported method of postmastectomy malignancy detection. In patients with greater known retained breast tissue, such as those with circumareolar or pedicled techniques, consideration may be given to alternative imaging modalities, although the efficacy and cost-utility of these techniques must still be proven. Preoperative patient counseling on the risk of breast cancer after gender-affirming mastectomy in addition to the unknown implications of residual breast tissue and long-term androgen exposure is critical. Patient awareness and education play an important role in shared decision-making, as further research is needed to define standards of medical and oncologic care in this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000007589","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T05:10:00Z","timestamp":1611637800000},"page":"213e-221e","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Oncologic Considerations for Safe Gender-Affirming Mastectomy: Preoperative Imaging, Pathologic Evaluation, Counseling, and Long-Term Screening"],"prefix":"10.1097","volume":"147","author":[{"given":"Ara A.","family":"Salibian","sequence":"first","affiliation":[{"name":"From the Hansj\u00f6rg Wyss Department of Plastic Surgery, the Department of Surgery, and the Division of Hematology and Medical Oncology, Department of Medicine, New York University Langone Health; the Advanced Center for Plastic Surgery; and the Division of Plastic Surgery, University of Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Axelrod","sequence":"additional","affiliation":[{"name":"From the Hansj\u00f6rg Wyss Department of Plastic Surgery, the Department of Surgery, and the Division of Hematology and Medical Oncology, Department of Medicine, New York University Langone Health; the Advanced Center for Plastic Surgery; and the Division of Plastic Surgery, University of Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Hansj\u00f6rg Wyss Department of Plastic Surgery, the Department of Surgery, and the Division of Hematology and Medical Oncology, Department of Medicine, New York University Langone Health; the Advanced Center for Plastic Surgery; and the Division of Plastic Surgery, University of Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Fischer","sequence":"additional","affiliation":[{"name":"From the Hansj\u00f6rg Wyss Department of Plastic Surgery, the Department of Surgery, and the Division of Hematology and Medical Oncology, Department of Medicine, New York University Langone Health; the Advanced Center for Plastic Surgery; and the Division of Plastic Surgery, University of Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cori","family":"Agarwal","sequence":"additional","affiliation":[{"name":"From the Hansj\u00f6rg Wyss Department of Plastic Surgery, the Department of Surgery, and the Division of Hematology and Medical Oncology, Department of Medicine, New York University Langone Health; the Advanced Center for Plastic Surgery; and the Division of Plastic Surgery, University of Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bluebond-Langner","sequence":"additional","affiliation":[{"name":"From the Hansj\u00f6rg Wyss Department of Plastic Surgery, the Department of Surgery, and the Division of Hematology and Medical Oncology, Department of Medicine, New York University Langone Health; the Advanced Center for Plastic Surgery; and the Division of Plastic Surgery, University of Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bjps.2018.01.003","article-title":"Quality of life improvement after chest wall masculinization in female-to-male transgender patients: A prospective study using the BREAST-Q and Body Uneasiness Test.","volume":"71","author":"Agarwal","year":"2018","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PRS.0000000000005113","article-title":"Assessing quality of life and patient-reported satisfaction with masculinizing top surgery: A mixed-methods descriptive survey study.","volume":"143","author":"Poudrier","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R4-20250501","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/SAP.0000000000001354","article-title":"Masculinizing top surgery: A systematic review of techniques and outcomes.","volume":"80","author":"Wilson","year":"2018","journal-title":"Ann Plast Surg"},{"key":"R5-20250501","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0960-9776(03)00033-X","article-title":"Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual.","volume":"12","author":"Burcombe","year":"2003","journal-title":"Breast"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/tbj.13417","article-title":"Breast cancer in a female to male transgender patient 20 years post-mastectomy: Issues to consider.","volume":"25","author":"Chotai","year":"2019","journal-title":"Breast J"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/jsm.12319","article-title":"Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.","volume":"10","author":"Gooren","year":"2013","journal-title":"J Sex Med"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12282-015-0661-4","article-title":"A very rare case of breast cancer in a female-to-male transsexual.","volume":"23","author":"Katayama","year":"2016","journal-title":"Breast Cancer"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1477-7819-10-280","article-title":"Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy.","volume":"10","author":"Nikolic","year":"2012","journal-title":"World J Surg Oncol"},{"key":"R11-20250501","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ejso.2018.06.021","article-title":"Breast cancer in transgender patients: A systematic review. Part 2: Female to male.","volume":"44","author":"Stone","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"873e","DOI":"10.1097\/PRS.0000000000003225","article-title":"Top surgery in transgender men: How far can you push the envelope?","volume":"139","author":"Bluebond-Langner","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1111\/j.1743-6109.2012.02939.x","article-title":"Subcutaneous mastectomy in female-to-male transsexuals: A retrospective cohort-analysis of 202 patients.","volume":"9","author":"Cregten-Escobar","year":"2012","journal-title":"J Sex Med"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.prs.0000299921.15447.b2","article-title":"Chest-wall contouring surgery in female-to-male transsexuals: A new algorithm.","volume":"121","author":"Monstrey","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bjps.2014.10.016","article-title":"Sexual reassignment surgery in female-to-male transsexuals: An algorithm for subcutaneous mastectomy.","volume":"68","author":"Wolter","year":"2015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R16-20250501","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.5597.83","article-title":"Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics.","volume":"2","author":"Symmers","year":"1968","journal-title":"BMJ"},{"key":"R17-20250501","first-page":"3652602","article-title":"Breast cancer development in a transgender male receiving testosterone therapy.","volume":"2018","author":"Barghouthi","year":"2018","journal-title":"Case Rep Endocrinol"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/tbj.13655","article-title":"Breast cancer in transgender female-to-male individuals: A case report of androgen receptor-positive breast cancer.","volume":"26","author":"Fundytus","year":"2020","journal-title":"Breast J"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clbc.2011.06.006","article-title":"Breast cancer in female-to-male transsexuals: Two cases with a review of physiology and management.","volume":"11","author":"Shao","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0037-1606103","article-title":"Breast cancer screening, management, and a review of case study literature in transgender populations.","volume":"35","author":"Deutsch","year":"2017","journal-title":"Semin Reprod Med"},{"key":"R21-20250501","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.9778\/cmajo.20180028","article-title":"Breast cancer risk and breast screening for trans people: An integration of 3 systematic reviews.","volume":"7","author":"Meggetto","year":"2019","journal-title":"CMAJ Open"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","article-title":"Incidence of breast cancer in a cohort of 5,135 transgender veterans.","volume":"149","author":"Brown","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R23-20250501","doi-asserted-by":"crossref","first-page":"l1652","DOI":"10.1136\/bmj.l1652","article-title":"Breast cancer risk in transgender people receiving hormone treatment: Nationwide cohort study in the Netherlands.","volume":"365","author":"de Blok","year":"2019","journal-title":"BMJ"},{"key":"R24-20250501","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group.","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"key":"R25-20250501","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1457496916645964","article-title":"Chest-wall contouring surgery in female-to-male transgender patients: A one-center retrospective analysis of applied surgical techniques and results.","volume":"106","author":"K\u00e4\u00e4ri\u00e4inen","year":"2017","journal-title":"Scand J Surg"},{"key":"R26-20250501","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/1471-0528.15258","article-title":"Breast and reproductive cancers in the transgender population: A systematic review.","volume":"125","author":"Joint","year":"2018","journal-title":"BJOG"},{"key":"R27-20250501","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00595-007-3758-3","article-title":"Clinicopathological study of breast tissue in female-to-male transsexuals.","volume":"38","author":"Kuroda","year":"2008","journal-title":"Surg Today"},{"key":"R28-20250501","first-page":"2572","article-title":"Serum and urinary androgens and risk of breast cancer in postmenopausal women.","volume":"51","author":"Secreto","year":"1991","journal-title":"Cancer Res"},{"key":"R29-20250501","doi-asserted-by":"crossref","first-page":"R257","DOI":"10.1530\/JME-14-0030","article-title":"Revising the role of the androgen receptor in breast cancer.","volume":"52","author":"Fioretti","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"R30-20250501","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-16-0167","article-title":"Cooperative dynamics of AR and ER activity in breast cancer.","volume":"14","author":"D\u2019Amato","year":"2016","journal-title":"Mol Cancer Res"},{"key":"R31-20250501","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr3599","article-title":"Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.","volume":"16","author":"Cochrane","year":"2014","journal-title":"Breast Cancer Res"},{"key":"R32-20250501","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies.","volume":"94","author":"Key","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R33-20250501","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","article-title":"Sex hormones and risk of breast cancer in premenopausal women: A collaborative reanalysis of individual participant data from seven prospective studies.","volume":"14","author":"Key","year":"2013","journal-title":"Lancet Oncol"},{"key":"R34-20250501","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ijc.28528","article-title":"Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status: Results from the EPIC cohort.","volume":"134","author":"Kaaks","year":"2014","journal-title":"Int J Cancer"},{"key":"R35-20250501","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/joe.0.1670053","article-title":"Role of androgens in proliferation and differentiation of mouse mammary epithelial cell line HC11.","volume":"167","author":"Baratta","year":"2000","journal-title":"J Endocrinol"},{"key":"R36-20250501","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/carcin\/19.12.2173","article-title":"Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: Probable mediation by steroid receptors.","volume":"19","author":"Liao","year":"1998","journal-title":"Carcinogenesis"},{"key":"R37-20250501","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/20.8.1597","article-title":"Sex hormone-induced mammary carcinogenesis in female noble rats: The role of androgens.","volume":"20","author":"Xie","year":"1999","journal-title":"Carcinogenesis"},{"key":"R38-20250501","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.fertnstert.2010.04.024","article-title":"Gene expression signatures of breast tissue before and after cross-sex hormone therapy in female-to-male transsexuals.","volume":"94","author":"Bentz","year":"2010","journal-title":"Fertil Steril"},{"key":"R39-20250501","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men.","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R40-20250501","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1990.tb17801.x","article-title":"Effect of long-term administration of androgens on breast tissues of female-to-male transsexuals.","volume":"586","author":"Sapino","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"R41-20250501","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","article-title":"Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population.","volume":"20","author":"Grynberg","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R42-20250501","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1369\/jhc.6A6928.2006","article-title":"Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.","volume":"54","author":"Slagter","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"R44-20250501","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk.","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"R45-20250501","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/PRS.0000000000004363","article-title":"BRCA mutations in the young, high-risk female population: Genetic testing, management of prophylactic therapies, and implications for plastic surgeons.","volume":"141","author":"Salibian","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R46-20250501","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2105\/AJPH.2015.302851","article-title":"Adherence to mammography screening guidelines among transgender persons and sexual minority women.","volume":"105","author":"Bazzi","year":"2015","journal-title":"Am J Public Health"},{"key":"R47-20250501","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jana.2010.02.004","article-title":"Providing care to transgender persons: A clinical approach to primary care, hormones, and HIV management.","volume":"21","author":"Williamson","year":"2010","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R48-20250501","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1472-6963-12-110","article-title":"\u201cCompletely out-at-sea\u201d with \u201ctwo-gender medicine\u201d: A qualitative analysis of physician-side barriers to providing healthcare for transgender patients.","volume":"12","author":"Snelgrove","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"R49-20250501","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3322\/caac.21446","article-title":"Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.","volume":"68","author":"Smith","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R50-20250501","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R51-20250501","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0033291704002776","article-title":"Sex reassignment: Outcomes and predictors of treatment for adolescent and adult transsexuals.","volume":"35","author":"Smith","year":"2005","journal-title":"Psychol Med"},{"key":"R52-20250501","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PRS.0000000000004948","article-title":"Anatomy of the superficial fascia system of the breast: A comprehensive theory of breast fascial anatomy.","volume":"142","author":"Rehnke","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R53-20250501","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/cncr.10429","article-title":"Incidence of the superficial fascia and its relevance in skin-sparing mastectomy.","volume":"94","author":"Beer","year":"2002","journal-title":"Cancer"},{"key":"R54-20250501","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PRS.0b013e3181f9589a","article-title":"Is oncologic safety compatible with a predictably viable mastectomy skin flap?","volume":"127","author":"Larson","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R55-20250501","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/bjs.9470","article-title":"Determinants of optimal mastectomy skin flap thickness.","volume":"101","author":"Robertson","year":"2014","journal-title":"Br J Surg"},{"key":"R57-20250501","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00268-010-0737-4","article-title":"Eleven-year follow-up of a randomized study of pectoral fascia preservation after mastectomy for early breast cancer.","volume":"34","author":"Dalberg","year":"2010","journal-title":"World J Surg"},{"key":"R58-20250501","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/trgh.2019.0040","article-title":"Establishing a cohort of transgender men and gender nonconforming individuals to understand the molecular impact of testosterone on breast physiology.","volume":"4","author":"Baker","year":"2019","journal-title":"Transgend Health"},{"key":"R59-20250501","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10549-019-05335-4","article-title":"Incidental breast carcinoma: Incidence, management, and outcomes in 4804 bilateral reduction mammoplasties.","volume":"177","author":"Tang","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"R60-20250501","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years\u2019 follow-up: A randomised controlled trial.","volume":"16","author":"Moss","year":"2015","journal-title":"Lancet Oncol"},{"key":"R61-20250501","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2214\/AJR.13.10810","article-title":"Breast imaging in the transgender patient.","volume":"202","author":"Phillips","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"R62-20250501","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.clbc.2018.11.007","article-title":"Interdisciplinary management of transgender individuals at risk for breast cancer: Case reports and review of the literature.","volume":"19","author":"Eismann","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"R63-20250501","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40134-018-0260-1","article-title":"Breast imaging of transgender individuals: A review.","volume":"6","author":"Sonnenblick","year":"2018","journal-title":"Curr Radiol Rep"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:22:41Z","timestamp":1746145361000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000007589","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,25]]}}}